# OnCo record precision-promise (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/precision-promise/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "precision-promise", "NCT04229004" ;
  schema:name "Precision Promise"@en ;
  schema:alternateName "Precision Promise trial"@en, "PanCAN Precision Promise"@en, "PRISM"@en ;
  schema:description "Precision Promise was the pancreatic cancer charity's attempt to copy I-SPY 2 for one of the cancers with the lowest survival: several new treatments tested at once against standard chemotherapy, with the trial itself learning which patients each helped. Its first two experimental drugs did not extend life, and the trial has closed."@en ;
  schema:url <https://onco.cc/trials/precision-promise/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04229004>, <https://pancan.org/research/precision-promise/> ;
  onco:status "completed" ;
  onco:phase "platform" ;
  schema:startDate "2020-01-31" ;
  onco:related <https://onco.cc/collections/pancan/> ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/folfirinox/>, <https://onco.cc/drugs/pamrevlumab/> ;
  onco:companies <https://onco.cc/companies/fibrogen/> ;
  onco:terms <https://onco.cc/terms/master-protocol/>, <https://onco.cc/terms/seamless-adaptive/>, <https://onco.cc/terms/interim-analysis/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-design/> .